Evidence map›Paper›PMID 39266637›Full record

ArticleLeukemia2024

Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study.

Florence Rabian, Sylvie Chevret, Bérengère Gruson, Sylvain Thépot, Anouk Walter-Petrich, Thorsten Braun, Norbert Vey, José Miguel Torregrosa-Diaz, Pierre Peterlin, Andrea Toma and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Florence RabianHematology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.
Sylvie ChevretSBIM, APHP, Hôpital Saint-Louis, INSERM, UMR-1153, ECSTRRA Team, Paris, France.
Bérengère GrusonHematology Department CHU Amiens, Amiens, France.
Sylvain ThépotHematology Department CHU Angers, Université Angers, Angers, France.
Anouk Walter-PetrichSBIM, APHP, Hôpital Saint-Louis, INSERM, UMR-1153, ECSTRRA Team, Paris, France.
Thorsten BraunHematology Department, Hôpital Avicenne, Université Sorbonne Paris Nord, Assistance Publique-Hôpitaux de Paris, Bobigny, France.
Norbert VeyHematology Department, Institut Paoli-Calmettes, Marseille, France.ORCID http://orcid.org/0000-0001-7027-040X
José Miguel Torregrosa-DiazService d'Hématologie Oncologique et Thérapie Cellulaire, CIC INSERM 1402, University Hospital of Poitiers, Poitiers, France.
Pierre PeterlinHematology Department CHU Nantes, Université Nantes, Nantes, France.
Andrea TomaGeriatric Hematology Unit, Hopitaux Universitaires Henri Mondor, Assistance Publique-Hopitaux-de-Paris, Draveil, France.
Maud D'AveniHematology Department, University Hospital of Nancy, Nancy, France.ORCID http://orcid.org/0000-0002-5909-2742
Jacques DelaunayHematology Unit, Hôpital Privé Le Confluent, Nantes, France.
Laurence LegrosDepartment of Hematology, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Kremlin-Bicêtre, France.
Nathalie DroinUniversité Paris Saclay, INSERM U1287, Gustave Roussy Cancer Center, Villejuif, France.
Fatiha ChermatGroupe Francophone des Myélodysplasies, F-75010, Paris, France.
Daniel LusinaHematology Laboratory, Hôpital Avicenne, Université Sorbonne Paris Nord, Assistance Publique-Hôpitaux de Paris, Bobigny, France.
Lionel AdèsHematology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.ORCID http://orcid.org/0000-0002-9020-8766
Rosa SapenaGroupe Francophone des Myélodysplasies, F-75010, Paris, France.
Eric SolaryUniversité Paris Saclay, INSERM U1287, Gustave Roussy Cancer Center, Villejuif, France.ORCID http://orcid.org/0000-0002-8629-1341
Pierre FenauxHematology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.
Raphael ItzyksonHematology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France. raphael.itzykson@aphp.fr.ORCID http://orcid.org/0000-0003-2139-6262

Funding

Institut National Du Cancer (French National Cancer Institute) INCa-DGOS-INSERM-ITMO Cancer_18008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39266637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.